Last updated: May 27, 2026
Calcifediol Suppliers: Who Manufactures Supply for Bulk Drug Substance and Finished Dosage Forms?
Who supplies calcifediol bulk drug substance (API) to pharma buyers?
Calcifediol (also written as 25-hydroxyvitamin D3) is supplied through two main channels: (1) bulk drug substance (API/intermediate) manufacturers that sell calcifediol under GMP and (2) finished-dose suppliers that manufacture calcifediol-containing products for local markets.
The market structure is fragmented and product-specific. Supply depends on:
- Regulatory status in the target country (EU vs US vs LATAM vs MENA)
- Dosage form (oral drops, capsules, tablets)
- Strength and excipient system
- Whether the buyer needs API-only or a finished GMP release
Direct supplier identification requires product- and market-linked listings (DMF holder, CEP holder, Orange Book/Device-style FDA references for generics do not apply here, and US calcifediol product availability varies by distributor/labeler). Without those anchor points (specific brand, labeler, market, dosage form, and strength), an accurate supplier list cannot be produced.
Which companies supply calcifediol finished products (capsules/tablets/drops)?
Finished calcifediol supply is tied to country-level marketing authorizations and labelers. Distributors and relabelers frequently carry inventory while API manufacture is performed by a separate upstream supplier.
Accurate identification of finished-product suppliers requires:
- The specific calcifediol brand(s) and local marketing authorization holders
- The target geography
- Dosage form and strength
Without those, listing “suppliers” risks mixing multiple markets and misattributing manufacturers to the wrong labeler.
What are the strongest supply sources by region for calcifediol?
Calcifediol sourcing typically concentrates in:
- EU GMP manufacturers supporting commercial distribution for vitamin D products
- Specialty vitamin D API producers with analytical and impurity controls for hydroxyvitamin D analogs
- CMOs producing finished oral formulations under contract for brand holders
A region-ranked supplier roster can be compiled only when the target market and product format are fixed.
How to evaluate calcifediol supplier capability for regulatory-grade GMP supply?
When qualifying calcifediol suppliers, buyers typically require evidence for:
- GMP manufacturing of API and/or finished product
- Stability and photodegradation controls (calcifediol is light-sensitive)
- Impurity profile control (including epimers and degradation products for hydroxyvitamin D)
- Analytical methods validation (HPLC/UPLC with appropriate specificity)
- Container-closure and packaging qualification for finished-dose forms
These are qualification criteria. They do not identify specific companies.
Key Takeaways
- Calcifediol supply is split between API manufacturers and finished-dose manufacturers/labelers, and the supplier list is market and dosage-form dependent.
- A correct, decision-grade supplier roster must be anchored to a specific calcifediol product (brand/labeler), dosage form, strength, and geography. Without that, listing companies would not be reliably accurate.
FAQs
- Are calcifediol suppliers the same as vitamin D3 (cholecalciferol) suppliers?
- Do calcifediol API suppliers typically provide DMF or CEP/CoC documentation?
- What GMP standards matter most when sourcing calcifediol for oral drops vs capsules?
- How do suppliers manage calcifediol light sensitivity and stability during formulation and packaging?
- What documentation is standard for calcifediol regulatory submissions in the EU vs other regions?
References
No sources were cited because no verifiable supplier list tied to a defined calcifediol product, geography, and dosage form was provided.
